Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT06585163Phase 1Completed
Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral Suspension
HealthyPK Drug-drug Interaction Study
PrincipalinvestigatorStart date: 2025-08-18
NCT05750017Phase 1Unknown
A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine
Herpes ZosterVaccine-Preventable Diseases
PrincipalinvestigatorStart date: 2023-03-23
NCT05523570Phase 1Completed
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension
Parkinson's Disease
PrincipalinvestigatorStart date: 2022-08-22
NCT04932005Phase 1Completed
A Study of DZD2269 in Healthy Adult Participants
Healthy Volunteers
PrincipalinvestigatorStart date: 2021-06-29

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06585163Phase 1PrincipalInvestigator

Study to Investigate the Safety, Tolerability and Pharmacokinetics of QEV-817 Oral Suspension

HealthyPK Drug-drug Interaction Study
Completed
NCT05750017Phase 1PrincipalInvestigator

A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine

Herpes ZosterVaccine-Preventable Diseases
Unknown
NCT05523570Phase 1PrincipalInvestigator

A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension

Parkinson's Disease
Completed
NCT04932005Phase 1PrincipalInvestigator

A Study of DZD2269 in Healthy Adult Participants

Healthy Volunteers
Completed
NCT04583228Phase 1PrincipalInvestigator

Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects

COVID 19
Completed

All 5 trials loaded